|
Jarosinski, M A; Reddy, P S; Anderson, W K (1993) Synthesis, chemical reactivity, and antitumor evaluation of congeners of carmethizole hydrochloride, an experimental ""acylated vinylogous carbinolamine"" tumor inhibitor. J Med Chem 36:3618-27
|
|
Anderson, W K; Dean, D C; Endo, T (1990) Synthesis, chemistry, and antineoplastic activity of alpha-halopyridinium salts: potential pyridone prodrugs of acylated vinylogous carbinolamine tumor inhibitors. J Med Chem 33:1667-75
|
|
Ebling, W F; Rich, S A; Szefler, S J et al. (1987) Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit. Eur J Drug Metab Pharmacokinet 12:50-7
|
|
Ebling, W F; Jusko, W J (1986) The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits. J Pharmacokinet Biopharm 14:557-99
|
|
Ebling, W F; Milsap, R L; Szefler, S J et al. (1986) 6 alpha-Methylprednisolone and 6 alpha-methylprednisone plasma protein binding in humans and rabbits. J Pharm Sci 75:760-3
|
|
Szefler, S J; Ebling, W F; Georgitis, J W et al. (1986) Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults. Eur J Clin Pharmacol 30:323-9
|
|
Ebling, W F; Szefler, S J; Jusko, W J (1985) Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man. Drug Metab Dispos 13:296-304
|
